1-20 of 32
Lisa Argnani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is CAR T a Drug or a Therapeutic Pathway? Systematic Review, (Re-)Estimation of Efficacy Endpoints and Metanalyses in Large B-Cell Lymphoma Real World Reports

Pier Luigi Zinzani, Rossana Di Staso, Beatrice Casadei, Frederick L. Locke, Michael D. Jain, Timothy Voorhees, Adam S Kittai, Mariana Bastos-Oreiro, Antonio Gutiérrez, Alejandro Martin Garcia-Sancho, Maria Jose Terol, Monica Mead, Michael J. Maranzano, Gloria Iacoboni, Pere Barba, Mi Kwon, Rebeca Bailen, Juan Luis Reguera, Agrima Mian, Brian T. Hill, Emmanuel Bachy, Franck Morschhauser, Roch Houot, Catherine Thieblemont, Steven Le Gouill, Riccardo Masetti, Davide Gori, Lisa Argnani
Journal: Blood
Blood (2023) 142 (Supplement 1): 6938.
https://doi.org/10.1182/blood-2023-178526
Published: 2023
Journal Articles

Role of Pegylated Liposomal Doxorubicin in Heavily Pretreated Relapsed Refractory Hodgkin Lymphoma Eligible for Autologous or Allogeneic Transplantation

Beatrice Casadei, Cinzia Pellegrini, Emanuele Sutto, Martina Cantelli, Lisa Argnani, Sabrina Zoli, Paolo Elia Coppola, Marianna Gentilini, Alice Morigi, Matteo Carella, Gabriele Gugliotta, Gianmarco Bagnato, Laura Nanni, Alessandro Broccoli, Vittorio Stefoni, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 6204.
https://doi.org/10.1182/blood-2023-178601
Published: 2023
Journal Articles

The Clinical Complexity of Langherans Cell Histiocytosis in Adult Patients: Experience of the Institute of Hematology of Bologna

Alessandro Broccoli, Gianmarco Bagnato, Lisa Argnani, Martina Cantelli, Beatrice Casadei, Cinzia Pellegrini, Sabrina Zoli, Emanuele Sutto, Paolo Elia Coppola, Marianna Gentilini, Alice Morigi, Matteo Carella, Gabriele Gugliotta, Laura Nanni, Vittorio Stefoni, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 6412.
https://doi.org/10.1182/blood-2023-178573
Published: 2023
Journal Articles

The Treatment of Burkitt Lymphoma with the Berlin-Frankfurt-Münster Protocol with Rituximab and Autologous Transplantation

Alessandro Broccoli, Gianmarco Bagnato, Lisa Argnani, Beatrice Casadei, Martina Cantelli, Cinzia Pellegrini, Sabrina Zoli, Emanuele Sutto, Paolo Elia Coppola, Marianna Gentilini, Alice Morigi, Matteo Carella, Gabriele Gugliotta, Laura Nanni, Vittorio Stefoni, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 6290.
https://doi.org/10.1182/blood-2023-178586
Published: 2023
Journal Articles

Critical Role of Hodgkin Lymphoma Cells-Derived Large and Small Extracellular Vesicles in the Regulation of the Immune-Inflammatory Microenvironment

Filippo Maltoni, Chiara Ciardiello, Laura Nanni, Martina Barone, Ghazal Narimanfar, Beatrice Casadei, Lisa Argnani, Alessandro Broccoli, Dorian Forte, Alfredo Budillon, Pier Luigi Zinzani, Lucia Catani
Journal: Blood
Blood (2022) 140 (Supplement 1): 11509–11511.
https://doi.org/10.1182/blood-2022-168706
Published: 2022
Journal Articles

Rituximab As an Effective Salvage Therapy in Pretreated Hairy Cell Leukemia Patients: The Bologna Experience

Alessandro Broccoli, Lisa Argnani, Laura Nanni, Gianmarco Bagnato, Matteo Carella, Beatrice Casadei, Paolo Elia Coppola, Gabriele Gugliotta, Ginevra Lolli, Marianna Gentilini, Alice Morigi, Cinzia Pellegrini, Vittorio Stefoni, Pier Luigi Zinzani
Journal: Blood
Blood (2022) 140 (Supplement 1): 6526–6527.
https://doi.org/10.1182/blood-2022-158158
Published: 2022
Journal Articles

Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling

Laura Nanni, Gerardo Musuraca, Alice Morigi, Vittorio Stefoni, Monica Barone, Gabriele Conti, Marco Fabbrini, Silvia Turroni, Alessandro Broccoli, Lisa Argnani, Patrizia Brigidi, Pier Luigi Zinzani
Journal: Blood
Blood (2022) 140 (Supplement 1): 4961–4963.
https://doi.org/10.1182/blood-2022-158175
Published: 2022
Journal Articles

Gut Microbiota Role in Response to Checkpoint Inhibitor Treatment in Patients with Relapsed/Refractory B-Cell Hodgkin Lymphoma: The MICRO-Linf Study

Beatrice Casadei, Serafina Guadagnuolo, Monica Barone, Silvia Turroni, Lisa Argnani, Patrizia Brigidi, Pier Luigi Zinzani
Journal: Blood
Blood (2021) 138 (Supplement 1): 2957.
https://doi.org/10.1182/blood-2021-146813
Published: 2021
Journal Articles

Brentuximab Vedotin As Single Agent in the Treatment of Relapsed/Refractory CD30 Positive Peripheral T-Cell Lymphoma Patients: A Phase 2 Study of the Fondazione Italiana Linfomi

Vittorio Stefoni, MD PhD, Paolo Corradini, Lorella Orsucci, MD, Stefano Volpetti, Lisa Argnani, Anna Dodero, Cinzia Pellegrini, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-136917
Published: 2020
Journal Articles

Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International Analysis

Juan Pablo Alderuccio, MD, Anne W. Beaven, MD, Geoffrey Shouse, DO, PhD, Narendranath Epperla, MDMS, Alexandra Stefanovic, MD, Pallawi Torka, MD, Jorge J. Castillo, MD, Lisa Argnani, Timothy J Voorhees, MD, Ash B Alpert, MD MFA, Sayan Chowdhury, PhD, Isildinha M. Reis, PhD, Wei Zhao, MD MS, Dali Edwards, Peter Martin, FRCPC, MD MS, Manali Kamdar, MD, Alex F. Herrera, MD, Jonathan W. Friedberg, MD MSSc, Pier Luigi Zinzani, MD, Izidore S. Lossos, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-137620
Published: 2020
Journal Articles

The Treatment of Hairy Cell Leukemia with a Focus on Long Lasting Responders to Cladribine: A Thirty-Year Experience from the Institute of Hematology of Bologna

Alessandro Broccoli, Carolina Terragna, Vittorio Stefoni, Cinzia Pellegrini, Beatrice Casadei, MD, Miriam Marangon, Alice Morigi, Laura Nanni, MD, Ginevra Lolli, Matteo Carella, Lisa Argnani, Michele Cavo, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4005.
https://doi.org/10.1182/blood-2019-122832
Published: 2019
Journal Articles

A Phase II Study of Brentuximab Vedotin (BV) in the Treatment of Elderly Hodgkin Lymphoma (HL) Patients at First Relapse or with Primary Refractory Disease — FIL_BVHD01

Lorenzo Tonialini, MD, Vittorio Stefoni, Alessandro Re, MD, Arben Lleshi, MD, Maurizio Bonfichi, MD, Antonello Pinto, Nicola Bianchetti, Lisa Argnani, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2920.
https://doi.org/10.1182/blood-2018-99-111812
Published: 2018
Journal Articles

PET/CT Guided Biopsy for the Diagnosis of Lymphoma

Alessandro Broccoli, Cristina Nanni, Alberta Cappelli, Francesco Bacci, MD, Alessandro Gasbarrini, Lucia Zanoni, Stefano Brocchi, Sebastiano Spagnolo, Carlo Piovani, Lisa Argnani, Stefano Boriani, Elena Sabattini, Rita Golfieri, Stefano Fanti, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2857.
https://doi.org/10.1182/blood.V130.Suppl_1.2857.2857
Published: 2017
Journal Articles

The Bbv Regimen: A Phase II Study with Bendamustine Plus Brentuximab Vedotin in Hodgkin Lymphoma and CD30+ Peripheral T-Cell Lymphoma in First Salvage Setting

Vittorio Stefoni, Beatrice Casadei, MD, Barbara Botto, Paolo Corradini, MD, Antonello Pinto, Alessandro Re, MD, Stefania Badiali, Lisa Argnani, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4087.
https://doi.org/10.1182/blood.V130.Suppl_1.4087.4087
Published: 2017
Journal Articles

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

Clinical Trials & Observations
Pier Luigi Zinzani, Cinzia Pellegrini, Annalisa Chiappella, Alice Di Rocco, Flavia Salvi, Maria Giuseppina Cabras, Lisa Argnani, Vittorio Stefoni
Journal: Blood
Blood (2017) 129 (16): 2328–2330.
https://doi.org/10.1182/blood-2017-01-764258
Published: 2017
Journal Articles

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

Cinzia Pellegrini, Luigi Rigacci, Caterina Patti, MD, Guido Gini, MD, Donato Mannina, MD, Monica Tani, Chiara Rusconi, MD, Alessandra Romano, MD PhD, Anna Vanazzi, MD, Barbara Botto, Carmelo Carlo-Stella, MD, Stefan Hohaus, Gian Matteo Rigolin, Pellegrino Musto, MD, Patrizio Mazza, MD, Stefano Molica, MD, Paolo Corradini, Angelo Fama, MD, Francesco Gaudio, Michele Merli, Angela Gravetti, Giuseppe Gritti, MD, Annalisa Arcari, Patrizia Tosi, Anna Marina Liberati, MD, Antonello Pinto, Vincenzo Pavone, MD, Filippo Gherlinzoni, MD, Virginia Naso, Stefano Volpetti, Andrea Visentin, MD, Maria Cecilia Goldaniga, MD, Maurizio Bonfichi, MD, Amalia De Renzo, Corrado Schiavotto, Michele Spina, Sergio Storti, MD, Angelo Michele Carella, Lisa Argnani, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3007.
https://doi.org/10.1182/blood.V128.22.3007.3007
Published: 2016
Journal Articles

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma

Alessandro Broccoli, MD, Alessandro Pulsoni, MD, Luigi Rigacci, Caterina Patti, MD, Guido Gini, MD, Donato Mannina, MD, Monica Tani, Chiara Rusconi, MD, Alessandra Romano, MD PhD, Anna Vanazzi, Barbara Botto, Armando Santoro, Stefan Hohaus, Gian Matteo Rigolin, Pellegrino Musto, Patrizio Mazza, MD, Stefano Molica, MD, Paolo Corradini, Angelo Fama, MD, Francesco Gaudio, Michele Merli, Fioravante Ronconi, Giuseppe Gritti, MD, Daniele Vallisa, MD, Patrizia Tosi, Anna Marina Liberati, MD, Antonello Pinto, Vincenzo Pavone, MD, Filippo Gherlinzoni, MD, Elena Cavalieri, MD, Stefano Volpetti, Andrea Visentin, MD, Maria Cecilia Goldaniga, MD, Maurizio Bonfichi, Amalia De Renzo, Corrado Schiavotto, Michele Spina, Angelo Michele Carella, Lisa Argnani, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4161.
https://doi.org/10.1182/blood.V128.22.4161.4161
Published: 2016
Journal Articles

Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients with Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma Treated in Italy According to the Ibrutinib Named Patient Program

Vittorio Stefoni, Federico Sottotetti, Manuel Gotti, Michele Spina, Stefano Volpetti, Simone Ferrero, Francesco Spina, MD, Francesco Pisani, Michele Merli, Carlo Visco, MD, Rossella Paolini, Vittorio Ruggero Zilioli, Luca Baldini, MD Prof, Nicola Di Renzo, Patrizia Tosi, Nicola Cascavilla, MD, Stefano Molica, MD, Lisa Argnani, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2985.
https://doi.org/10.1182/blood.V128.22.2985.2985
Published: 2016
Journal Articles

Long-Term Responders after Brentuximab Vedotin: Experience on 57 Patients with Relapsed and Refractory Hodgkin and Anaplastic Large Cell Lymphoma

Pier Luigi Zinzani, MD PhD, Letizia Gandolfi, Beatrice Casadei, Cinzia Pellegrini, Alessandro Broccoli, MD, Enrico Derenzini, MD, Federica Quirini, Lorenzo Tonialini, Michele Cavo, MD, Lisa Argnani, Vittorio Stefoni
Journal: Blood
Blood (2015) 126 (23): 2725.
https://doi.org/10.1182/blood.V126.23.2725.2725
Published: 2015
Journal Articles

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice, the Lenamant Study

Vittorio Stefoni, Cinzia Pellegrini, Letizia Gandolfi, Luca Baldini, Monica Tani, Emanuele Cencini, Amalia Figuera, Michela Ansuinelli, Elisa Bernocco, Maria Cantonetti, M. Christina Cox, MD, Filippo Ballerini, MD, Chiara Rusconi, MD, Carlo Visco, MD, Luca Arcaini, Angela Fama, Roberto Marasca, Francesco Zaja, Alessia Castellino, Catello Califano, Marina Cavaliere, Guido Gini, MD, Anna Marina Liberati, Gerardo Musuraca, MD, Anna Lucania, Giuseppina Ricciuti, Lisa Argnani, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3946.
https://doi.org/10.1182/blood.V126.23.3946.3946
Published: 2015